Business
Elanco Animal Health Inc: our business, growth strategies, distribution strategies, product development efforts and future expenses.
Revenue increased 6.2% to $4.71B, while Net income decreased 168.6% to ($232.0M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $4.71BWatch
- Profitability — Net income ($232.0M)Watch
- Cash generation — Free cash flow $284.0MOK
- Accounting — Distress score not computed · no manipulation flag · earnings quality safeNote
- Insiders — 4 buys; 0 sells in 365 daysOK
- Capital — Comparable payout data unavailableNote
Where the revenue comes from
Fiscal 2025, as Elanco Animal Health Inc reports it. History and quarterly detail are in the app.
- Farm Animal:$2.4B
- Pet Health$2.3B
- Contract Manufacturing and Other$53.0M
Leadership changes
From Elanco Animal Health Inc's own filings, the day they're filed.
- Stacey Ma · Directors · appointmenteff. 2024-11-11
- Kathy Turner · directors · appointment
- Ancora Parties · appointment
Latest filings
- 8-K · Company announcement2026-08-05
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-05-27
- 8-K · Company announcement2026-05-06
- 10-Q · Quarterly report2026-05-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Elanco Animal Health Inc, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.